Parkinson’s Study to Use mHealth Wearables to Gather Real-Time Data

Researchers at the University of Rochester will be using mHealth wearables to gather continuous, real-time data on how people living with Parkinson’s and Huntington’s Disease go through each day. The New York university is partnering with MC10, a Lexington, MA-based developer of the digital health wearable Biostamp nPoint, to study the progressive effects of Central Nervous System (CNS) diseases, particularly those involving movement disorders. “Movement disorders such as Huntington’s and Parkinson’s disease represent a therapeutic area that lacks objective, quantitative understanding of disease progression, and therapeutic efficacy,” Dr. Arthur Combs, MD, MC10’s Chief Medical Officer, said in a press release. “The goals of this research collaboration are to enhance the way we assess people with CNS diseases, improve the way therapies are evaluated, and transform the way these patients are managed toward better outcomes.”